1
|
A. Abd El-Ghany W. Avian Metapneumovirus Infection in Poultry Flocks: A Review of Current Knowledge. PERTANIKA JOURNAL OF TROPICAL AGRICULTURAL SCIENCE 2023; 46:971-1002. [DOI: 10.47836/pjtas.46.3.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/01/2023]
Abstract
Avian metapneumovirus (aMPV) is one of the respiratory viruses that cause global economic losses in poultry production systems. Therefore, it was important to design a comprehensive review article that gives more information about aMPV infection regarding the distribution, susceptibility, transmission, pathogenesis, pathology, diagnosis, and prevention. The aMPV infection is characterized by respiratory and reproductive disorders in turkeys and chickens. The disease condition is turkey rhinotracheitis in turkeys and swollen head syndrome in chickens. Infection with aMPV is associated with worldwide economic losses, especially in complications with other infections or poor environmental conditions. The genus Metapneumovirus is a single-stranded enveloped RNA virus and contains A, B, C, and D subtypes. Meat and egg-type birds are susceptible to aMPV infection. The virus can transmit through aerosol, direct contact, mechanical, and vertical routes. The disease condition is characterized by respiratory manifestations, a decrease in egg production, growth retardation, increasing morbidity rate, and sometimes nervous signs and a high mortality rate, particularly in concurrent infections. Definitive diagnosis of aMPV is based mainly on isolation and identification methods, detection of the viral DNA, as well as seroconversion. Prevention of aMPV infection depends on adopting biosecurity measures and vaccination using inactivated, live attenuated, and recombinant or DNA vaccines.
Collapse
|
2
|
Kaboudi K, Lachheb J. Avian metapneumovirus infection in turkeys: a review on turkey rhinotracheitis. J APPL POULTRY RES 2021. [DOI: 10.1016/j.japr.2021.100211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
3
|
A Reverse Genetics Approach for the Design of Methyltransferase-Defective Live Attenuated Avian Metapneumovirus Vaccines. Methods Mol Biol 2016. [PMID: 27076293 DOI: 10.1007/978-1-4939-3389-1_7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/01/2023]
Abstract
Avian metapneumovirus (aMPV), also known as avian pneumovirus or turkey rhinotracheitis virus, is the causative agent of turkey rhinotracheitis and is associated with swollen head syndrome in chickens. aMPV belongs to the family Paramyxoviridae which includes many important human pathogens such as human respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and human parainfluenza virus type 3 (PIV3). The family also includes highly lethal emerging pathogens such as Nipah virus and Hendra virus, as well as agriculturally important viruses such as Newcastle disease virus (NDV). For many of these viruses, there is no effective vaccine. Here, we describe a reverse genetics approach to develop live attenuated aMPV vaccines by inhibiting the viral mRNA cap methyltransferase. The viral mRNA cap methyltransferase is an excellent target for the attenuation of paramyxoviruses because it plays essential roles in mRNA stability, efficient viral protein translation and innate immunity. We have described in detail the materials and methods used to generate recombinant aMPVs that lack viral mRNA cap methyltransferase activity. We have also provided methods to evaluate the genetic stability, pathogenesis, and immunogenicity of live aMPV vaccine candidates in turkeys.
Collapse
|
4
|
Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain. J Virol 2014; 88:12348-63. [PMID: 25122790 DOI: 10.1128/jvi.01095-14] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
UNLABELLED Avian metapneumovirus (aMPV), also known as avian pneumovirus or turkey rhinotracheitis virus, is the causative agent of turkey rhinotracheitis and is associated with swollen head syndrome in chickens. Since its discovery in the 1970s, aMPV has been recognized as an economically important pathogen in the poultry industry worldwide. The conserved region VI (CR VI) of the large (L) polymerase proteins of paramyxoviruses catalyzes methyltransferase (MTase) activities that typically methylate viral mRNAs at guanine N-7 (G-N-7) and ribose 2'-O positions. In this study, we generated a panel of recombinant aMPV (raMPV) Colorado strains carrying mutations in the S-adenosyl methionine (SAM) binding site in the CR VI of L protein. These recombinant viruses were specifically defective in ribose 2'-O, but not G-N-7 methylation and were genetically stable and highly attenuated in cell culture and viral replication in the upper and lower respiratory tracts of specific-pathogen-free (SPF) young turkeys. Importantly, turkeys vaccinated with these MTase-defective raMPVs triggered a high level of neutralizing antibody and were completely protected from challenge with homologous aMPV Colorado strain and heterologous aMPV Minnesota strain. Collectively, our results indicate (i) that aMPV lacking 2'-O methylation is highly attenuated in vitro and in vivo and (ii) that inhibition of mRNA cap MTase can serve as a novel target to rationally design live attenuated vaccines for aMPV and perhaps other paramyxoviruses. IMPORTANCE Paramyxoviruses include many economically and agriculturally important viruses such as avian metapneumovirus (aMPV), and Newcastle disease virus (NDV), human pathogens such as human respiratory syncytial virus, human metapneumovirus, human parainfluenza virus type 3, and measles virus, and highly lethal emerging pathogens such as Nipah virus and Hendra virus. For many of them, there is no effective vaccine or antiviral drug. These viruses share common strategies for viral gene expression and replication. During transcription, paramyxoviruses produce capped, methylated, and polyadenylated mRNAs. Using aMPV as a model, we found that viral ribose 2'-O methyltransferase (MTase) is a novel approach to rationally attenuate the virus for vaccine purpose. Recombinant aMPV (raMPV) lacking 2'-O MTase were not only highly attenuated in turkeys but also provided complete protection against the challenge of homologous and heterologous aMPV strains. This novel approach can be applicable to other animal and human paramyxoviruses for rationally designing live attenuated vaccines.
Collapse
|
5
|
Wei Y, Feng K, Yao X, Cai H, Li J, Mirza AM, Iorio RM, Li J. Localization of a region in the fusion protein of avian metapneumovirus that modulates cell-cell fusion. J Virol 2012; 86:11800-14. [PMID: 22915815 PMCID: PMC3486300 DOI: 10.1128/jvi.00232-12] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2012] [Accepted: 08/12/2012] [Indexed: 11/20/2022] Open
Abstract
The genus Metapneumovirus within the subfamily Pneumovirinae of the family Paramyxoviridae includes two members, human metapneumovirus (hMPV) and avian metapneumovirus (aMPV), causing respiratory tract infections in humans and birds, respectively. Paramyxoviruses enter host cells by fusing the viral envelope with a host cell membrane. Membrane fusion of hMPV appears to be unique, in that fusion of some hMPV strains requires low pH. Here, we show that the fusion (F) proteins of aMPV promote fusion in the absence of the attachment protein and low pH is not required. Furthermore, there are notable differences in cell-cell fusion among aMPV subtypes. Trypsin was required for cell-cell fusion induced by subtype B but not subtypes A and C. The F protein of aMPV subtype A was highly fusogenic, whereas those from subtypes B and C were not. By construction and evaluation of chimeric F proteins composed of domains from the F proteins of subtypes A and B, we localized a region composed of amino acid residues 170 to 338 in the F protein that is responsible for the hyperfusogenic phenotype of the F from subtype A. Further mutagenesis analysis revealed that residues R295, G297, and K323 in this region collectively contributed to the hyperfusogenicity. Taken together, we have identified a region in the aMPV F protein that modulates the extent of membrane fusion. A model for fusion consistent with these data is presented.
Collapse
Affiliation(s)
- Yongwei Wei
- Department of Food Science and Technology, College of Food, Agricultural and Environmental Sciences
| | - Kurtis Feng
- Department of Food Science and Technology, College of Food, Agricultural and Environmental Sciences
| | - Xiangjie Yao
- Department of Food Science and Technology, College of Food, Agricultural and Environmental Sciences
| | - Hui Cai
- Department of Food Science and Technology, College of Food, Agricultural and Environmental Sciences
| | - Junan Li
- Division of Environmental Health Sciences, College of Public Health
| | - Anne M. Mirza
- Department of Microbiology and Physiological Systems
| | - Ronald M. Iorio
- Department of Microbiology and Physiological Systems
- Program in Immunology and Virology, University of Massachusetts Medical School, Worcester, Massachusetts, USA
| | - Jianrong Li
- Department of Food Science and Technology, College of Food, Agricultural and Environmental Sciences
- Division of Environmental Health Sciences, College of Public Health
- Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA
| |
Collapse
|
6
|
Zhang Y, Wei Y, Li J, Li J. Development and optimization of a direct plaque assay for human and avian metapneumoviruses. J Virol Methods 2012; 185:61-8. [PMID: 22684013 DOI: 10.1016/j.jviromet.2012.05.030] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2012] [Revised: 05/25/2012] [Accepted: 05/30/2012] [Indexed: 11/18/2022]
Abstract
The genus Metapneumovirus within the subfamily Pneumovirinae and family Paramyxoviridae includes only two viruses, human metapneumovirus (hMPV) and avian metapneumovirus (aMPV), which cause respiratory disease in humans and birds, respectively. These two viruses grow poorly in cell culture and other quantitation methods, such as indirect immuno-staining and immuno-fluorescent assays, are expensive, time consuming, and do not allow for plaque purification of the virus. In order to enhance research efforts for studying these two viruses, a direct plaque assay for both hMPV and aMPV has been developed. By optimizing the chemical components of the agarose overlay, it was found that both hMPV with a trypsin-independent F cleavage site and aMPV formed clear and countable plaques in a number of mammalian cell lines (such as Vero-E6 and LLC-MK2 cells) after 5 days of incubation. The plaque forming assay has similar sensitivity and reliability as the currently used immunological methods for viral quantitation. The plaque assay is also a more simple, rapid, and economical method compared to immunological assays, and in addition allows for plaque purification of the viruses. The direct plaque assay will be a valuable method for the quantitation and evaluation of the biological properties of some metapneumoviruses.
Collapse
Affiliation(s)
- Yu Zhang
- Department of Food Science and Technology, College of Food, Agricultural and Environmental Sciences, The Ohio State University, Columbus, OH 43210, USA
| | | | | | | |
Collapse
|
7
|
Lou F, Neetoo H, Li J, Chen H, Li J. Lack of correlation between virus barosensitivity and the presence of a viral envelope during inactivation of human rotavirus, vesicular stomatitis virus, and avian metapneumovirus by high-pressure processing. Appl Environ Microbiol 2011; 77:8538-47. [PMID: 22003028 PMCID: PMC3233080 DOI: 10.1128/aem.06711-11] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2011] [Accepted: 10/08/2011] [Indexed: 11/20/2022] Open
Abstract
High-pressure processing (HPP) is a nonthermal technology that has been shown to effectively inactivate a wide range of microorganisms. However, the effectiveness of HPP on inactivation of viruses is relatively less well understood. We systematically investigated the effects of intrinsic (pH) and processing (pressure, time, and temperature) parameters on the pressure inactivation of a nonenveloped virus (human rotavirus [HRV]) and two enveloped viruses (vesicular stomatitis virus [VSV] and avian metapneumovirus [aMPV]). We demonstrated that HPP can efficiently inactivate all tested viruses under optimal conditions, although the pressure susceptibilities and the roles of temperature and pH substantially varied among these viruses regardless of the presence of a viral envelope. We found that VSV was much more stable than most food-borne viruses, whereas aMPV was highly susceptible to HPP. When viruses were held for 2 min under 350 MPa at 4°C, 1.1-log, 3.9-log, and 5.0-log virus reductions were achieved for VSV, HRV, and aMPV, respectively. Both VSV and aMPV were more susceptible to HPP at higher temperature and lower pH. In contrast, HRV was more easily inactivated at higher pH, although temperature did not have a significant impact on inactivation. Furthermore, we demonstrated that the damage of virion structure by disruption of the viral envelope and/or capsid is the primary mechanism underlying HPP-induced viral inactivation. In addition, VSV glycoprotein remained antigenic although VSV was completely inactivated. Taken together, our findings suggest that HPP is a promising technology to eliminate viral contaminants in high-risk foods, water, and other fomites.
Collapse
Affiliation(s)
- Fangfei Lou
- Department of Food Science and Technology, College of Food, Agricultural and Environmental Sciences
| | - Hudaa Neetoo
- Department of Animal and Food Sciences, University of Delaware, Newark, Delaware 19716
| | - Junan Li
- Division of Environmental Health Sciences, College of Public Health
| | - Haiqiang Chen
- Department of Animal and Food Sciences, University of Delaware, Newark, Delaware 19716
| | - Jianrong Li
- Department of Food Science and Technology, College of Food, Agricultural and Environmental Sciences
- Division of Environmental Health Sciences, College of Public Health
- Center for RNA Biology, The Ohio State University, Columbus, Ohio 43210
| |
Collapse
|
8
|
Rubbenstroth D, Ryll M, Behr KP, Rautenschlein S. Pathogenesis ofRiemerella anatipestiferin turkeys after experimental mono-infection via respiratory routes or dual infection together with the avian metapneumovirus. Avian Pathol 2009; 38:497-507. [DOI: 10.1080/03079450903349220] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
9
|
Tiwari A, Patnayak DP, Goyal SM. Attempts to improve on a challenge model for subtype C avian pneumovirus. Avian Pathol 2006; 35:117-21. [PMID: 16595303 DOI: 10.1080/03079450600597675] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Respiratory disease caused by avian pneumovirus (APV) has a strong negative impact on the economy of the turkey industry in many countries. Progress in developing vaccines against this infection in the US has been slow partly because of the lack of a consistent challenge model to conduct vaccine efficacy studies. This study was designed to determine whether in vivo passages of a US isolate of APV, designated subtype C (APV-C), would increase virus virulence, leading to consistent clinical signs in turkeys. Three different experiments were performed. In experiments 1 and 2, a cell culture adapted APV was passaged four times in vivo in turkeys. Following each passage, clinical signs were found to increase in severity. In addition, inoculated birds were found to shed both APV RNA (by reverse transcriptase-polymerase chain reaction) and live virus (by virus isolation) at each passage. The mean antibody titres also increased with each passage. The results of the second experiment were not in complete agreement with those of experiment 1. In the third experiment, APV grown in three different cell lines was inoculated into three groups of turkeys. Clinical signs were observed in inoculated birds and virus could be isolated from all three groups. The results of this preliminary study indicate that in vivo passage of APV-C in birds may increase virus virulence, but the results obtained in experiment 2 suggest that further studies are needed to confirm this.
Collapse
Affiliation(s)
- A Tiwari
- Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, 1333 Gortner Avenue, St Paul, MN 55108, USA
| | | | | |
Collapse
|
10
|
Banet-Noach C, Simanov L, Perk S. Characterization of Israeli avian metapneumovirus strains in turkeys and chickens. Avian Pathol 2005; 34:220-6. [PMID: 16191705 DOI: 10.1080/03079450500112625] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Although the disease associated with the avian metapneumovirus (aMPV) has been described in Israel for more than 20 years and one Israeli isolate was characterized as subtype A, this is the first study investigating the strains circulating in Israel (period 2002 to 2004). Viral RNA was detected by reverse transcription-polymerase chain reaction in 44% of the examined flocks, and one-half of the virus isolation attempts were successful. Characterization showed that 34 non-vaccinated turkey flocks had aMPV subtype B, three had aMPV subtype A and three remained undetermined. Sequence analysis of part of the attachment protein G gene (1161 base pairs) showed a relative homogeneity within the Israeli subtype B group, although they were different from the European and vaccine strains. Seven out of 10 vaccinated flocks were reverse transcription-polymerase chain reaction-positive for aMPV, and sequence analysis of 239 base pairs of the G gene revealed that field strains and not vaccine strains were recovered from these flocks. Overall, the virological examination confirmed the high prevalence of aMPV in Israel and revealed a co-circulation of two subtypes, A and B, with aMPV subtype B being the dominant subtype.
Collapse
Affiliation(s)
- Caroline Banet-Noach
- Division of Avian and Aquatic Diseases, Kimron Veterinary Institute, Beit Dagan, Israel.
| | | | | |
Collapse
|
11
|
Patnayak DP, Goyal SM. Duration of immunity produced by a live attenuated vaccine against avian pneumovirus type C. Avian Pathol 2004; 33:465-9. [PMID: 15545025 DOI: 10.1080/03079450400003676] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
A recently developed live, attenuated vaccine against avian pneumovirus (APV) was found to be safe and protective in experimental birds. Duration of immunity following a single dose of this experimental vaccine in 1-week-old turkey poults is described. Two groups each of 60 poults were housed in separate isolation rooms. Birds in group one were inoculated oculonasally at 1 week of age with the vaccine. The second group served as a non-vaccinated group and was inoculated with mock-infected cell culture fluid. At 3, 7, 10, and 14 weeks post vaccination, 15 birds from each of the groups were removed to separate isolation rooms and challenged with virulent APV. Taken together, data on clinical signs and virus detection in choanal swabs following each challenge indicated that the vaccine was able to protect birds for up to 14 weeks post vaccination. Peak antibody levels were attained 7 weeks post vaccination and declined thereafter. These results indicated that this experimental vaccine induced protection against APV even in the absence of high antibody titres.
Collapse
Affiliation(s)
- Devi P Patnayak
- Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, St Paul, MN 55108, USA
| | | |
Collapse
|